(Q36149059)

English

Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Europe PubMed Central

Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

systematic review

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Zacny J

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Zamakhshary M

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Veldhuyzen van Zanten S

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1299-1312

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15932360%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Long term acid suppressing treatment in general practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Who is using chronic acid suppression therapy and why?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Helicobacter pylori: from bench to bedside

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Gastro-oesophageal reflux during day case gynaecological laparoscopy under positive pressure ventilation: laryngeal mask vs. tracheal intubation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Comparison of the gastroduodenal tolerance of tenoxicam and diclofenac Na. A double-blind, endoscopically controlled study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On-demand therapy in gastroesophageal reflux disease: a comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Time to relief of episodic symptoms of gastro-oesophageal reflux disease. A crossover comparison of single doses of the effervescent and standard formulations of ranitidine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Proton pump inhibitors and the time trends for esophageal dilation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Nonerosive reflux disease--current concepts and dilemmas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02490.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36149059&oldid=2006734902"